Liquidia Inc. (LQDA) - Cash Funds Calculated per Share

Corporate emblem and logo of liquidia.com (LQDA)

Liquidia Corporation (LQDA) develops innovative powder medications to combat pulmonary hypertension, leveraging a streamlined supply chain and warehouse reserves. Cash per share demonstrates financial stability, where 4.36 captures the value of this parameter. Simultaneously, the company is implementing eco-design for inhalers and reducing harmful emissions while modernizing its production capacities.

Liquidia Technologies - LQDA Cash per Share (period 07/04/2022 - 11/20/2026)

Analytical breakdowns for Liquidia (LQDA)

- cash position and cash flow details:
Summary company analysis:LQDA Liquidia Inc.
Core merchandise of liquidia.com

For Liquidia Corporation (LQDA), which is advancing the commercialization of pulmonary hypertension treatments, the balance between liquidity and expansion investments is critical. This metric is calculated by dividing total cash reserves by the number of shares outstanding, allowing for an assessment of the intrinsic value of an investor's stake. By analyzing the cash per share chart, one can determine the risk of inefficient capital allocation or the existence of a financial buffer to protect investments.

Analysis of competing companies

Cash on Hand per Share Haleon Corp HLN|Cash per Single Share KVUE (Kenvue Health)|Verona Pharma plc - Cash Funds per Single Share|Jyong Biotech - Cash per Single Share|LGND: Cash Funds per Single Share|AMRX: Cash per Single Share|Cash on Hand per Share Perrigo Company plc|ALVO: Cash per Share|Cash on Hand per Share glpg.com (GLPG)|Cash Funds per Share ANI Pharmaceuticals Inc|MNKD: Amount of Cash per Share|Cash per Single Share AMPH (Amphastar)|PCRX - Cash on Hand per Share|Cash per Share SPRY (ars-pharma.com)|Amount of Cash per Share TBPH|Aquestive Therapeutics, Inc. - Cash per Share|scpharmaceuticals.com - Cash Calculated per Single Share|Tectonic (TECX) - Cash Funds per Share|Cash per Single Share Tonix Pharmaceuticals Inc.|Cash Funds per Share sxtchina.com|Cash per Single Share Eupraxia Pharmaceuticals (EPRX)|Cash per Share BHST|EXOZ - Cash on Hand per Share|Oramed - Cash per Single Share|Entera Bio Ltd. (ENTX) - Cash on Hand per Share|HYFT - Cash Funds per Share|ABVC: Cash Funds per Share|CPIX: Cash per Share|Quantum BioPharma Ltd. - Amount of Cash per Share|FGEN (FibroGen Corp) - Cash per Share|Telomir Pharma (TELO) - Cash Funds Calculated per Share|Cash Funds per Share Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Amount of Cash per Share|Cash Funds per Share Rallybio Corporation RLYB|LEXX: Cash Funds per Single Share|PULM - Cash Funds per Share|Amount of Cash per Share PTHL (Pheton Holdings)|Aptorum (APM) - Cash Funds per Share|LYRA (Lyra Therapeutics) - Cash Funds per Share|Cash Funds per Share Impact BioMedical Inc|TNF Pharmaceuticals - Cash Money per Share|Cash per Share YCBD|Cash per Share PainReform Ltd. (PRFX)|Cash Funds per Share Altamira Therapeutics Ltd CYTO|LIPO (lipella.com) - Cash Money per Share|OptiNose - Cash per Share|Cash Money per Share PIRS|PROC: Cash per Share|Petros - Amount of Cash per Share|Cash per Single Share QLI|SLRN: Amount of Cash per Share|Cash per Single Share TFFP (TFF Pharmaceuticals, Inc.)